115 related articles for article (PubMed ID: 15640959)
41. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
42. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
Rydén L; Stendahl M; Jonsson H; Emdin S; Bengtsson NO; Landberg G
Breast Cancer Res Treat; 2005 Jan; 89(2):135-43. PubMed ID: 15692755
[TBL] [Abstract][Full Text] [Related]
43. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen.
Kopp A; Jonat W; Schmahl M; Knabbe C
Cancer Res; 1995 Oct; 55(20):4512-5. PubMed ID: 7553618
[TBL] [Abstract][Full Text] [Related]
44. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
45. VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Li ZD; Bork JP; Krueger B; Patsenker E; Schulze-Krebs A; Hahn EG; Schuppan D
Biochem Biophys Res Commun; 2005 Sep; 334(4):1049-60. PubMed ID: 16039615
[TBL] [Abstract][Full Text] [Related]
46. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
Nilsson UW; Jönsson JA; Dabrosin C
Exp Cell Res; 2009 Jan; 315(1):1-9. PubMed ID: 18996114
[TBL] [Abstract][Full Text] [Related]
47. The effect of tamoxifen on expression of ER, PR, Cerb-B2, and ki-67 in C3H mice spontaneous breast cancer model and the relation with chemotherapeutic effect.
Li X; Zhang S; Liu W; Li H
Cell Biochem Biophys; 2014 Dec; 70(3):1875-9. PubMed ID: 25168102
[TBL] [Abstract][Full Text] [Related]
48. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
Gupta S; Joshi K; Wig JD; Arora SK
Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
[TBL] [Abstract][Full Text] [Related]
49. The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesis.
Ozkan K; Eralp L; Kocaoglu M; Ahishali B; Bilgic B; Mutlu Z; Turker M; Ozkan FU; Sahin K; Guven M
Growth Factors; 2007 Apr; 25(2):101-7. PubMed ID: 17891595
[TBL] [Abstract][Full Text] [Related]
50. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
Asano-Kato N; Fukagawa K; Okada N; Kawakita T; Takano Y; Dogru M; Tsubota K; Fujishima H
Exp Eye Res; 2005 Apr; 80(4):555-60. PubMed ID: 15781283
[TBL] [Abstract][Full Text] [Related]
51. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
52. Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis.
Abu El-Asrar AM; Al-Mansouri S; Tabbara KF; Missotten L; Geboes K
Eye (Lond); 2006 Jan; 20(1):71-9. PubMed ID: 15746957
[TBL] [Abstract][Full Text] [Related]
53. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
54. [Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps].
Guo J; Wang X; Tao G; Zhang H; Zhu X; Zhang W; Fan E; Han D
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):83-6. PubMed ID: 12761968
[TBL] [Abstract][Full Text] [Related]
55. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome.
Cheong HI; Lee JH; Hahn H; Park HW; Ha IS; Choi Y
J Nephrol; 2001; 14(4):263-9. PubMed ID: 11506248
[TBL] [Abstract][Full Text] [Related]
56. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
57. TGF-β1 and BRCA2 expression are associated with clinical factors in breast cancer.
Li J; Zhu H; Chen T; Dai G; Zou L
Cell Biochem Biophys; 2011 Jul; 60(3):245-8. PubMed ID: 21222048
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-alpha and endocrine sensitivity in breast cancer.
Nicholson RI; McClelland RA; Gee JM; Manning DL; Cannon P; Robertson JF; Ellis IO; Blamey RW
Cancer Res; 1994 Apr; 54(7):1684-9. PubMed ID: 8137282
[TBL] [Abstract][Full Text] [Related]
59. Role of the aging vasculature and Erb B-2 signaling in epidermal growth factor-dependent intravasion of breast carcinoma cells.
Price DJ; Avraham S; Jiang S; Fu Y; Avraham HK
Cancer; 2004 Jul; 101(1):198-205. PubMed ID: 15222007
[TBL] [Abstract][Full Text] [Related]
60. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.
Nakopoulou L; Stefanaki K; Panayotopoulou E; Giannopoulou I; Athanassiadou P; Gakiopoulou-Givalou H; Louvrou A
Hum Pathol; 2002 Sep; 33(9):863-70. PubMed ID: 12378509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
